- Q4 2023 Theriva Biologics Inc Earnings Call TranscriptMar 25, 2024$0.49377 (-5.04%)Earnings
- Q3 2023 Theriva Biologics Inc Earnings Call TranscriptNov 13, 2023$0.4402 (-6.34%)Earnings
- Q2 2023 Theriva Biologics Inc Earnings Call TranscriptAug 08, 2023$0.6272 (-2.15%)Earnings
- Q1 2023 Theriva Biologics Inc Earnings Call TranscriptMay 11, 2023$0.6888 (-3.33%)Earnings
- Q4 2022 Theriva Biologics Inc Earnings Call TranscriptMar 30, 2023$0.6801 (+0.01%)Earnings
- Q3 2022 Theriva Biologics Inc Earnings Call TranscriptNov 11, 2022$0.61675 (-3.90%)Earnings
- Theriva Biologics Inc KOL Webinar TranscriptNov 07, 2022
- Q2 2022 Synthetic Biologics Inc Earnings Call TranscriptAug 11, 2022$1.42Earnings
- Q1 2022 Synthetic Biologics Inc Earnings Call TranscriptMay 16, 2022$2.3 (+0.61%)Earnings
- Q4 2021 Synthetic Biologics Inc Earnings Call TranscriptMar 16, 2022$2.52 (+5.04%)Earnings
- Synthetic Biologics Inc Operational Update Call TranscriptDec 14, 2021
- Q3 2021 Synthetic Biologics Inc Earnings Call TranscriptNov 03, 2021$4.33 (-3.05%)Earnings
- Q2 2021 Synthetic Biologics Inc Earnings Call TranscriptAug 05, 2021$5.08 (-0.35%)Earnings
- Q1 2021 Synthetic Biologics Inc Earnings Call TranscriptMay 05, 2021$5.06 (-2.09%)Earnings
- Full Year 2020 Synthetic Biologics Inc Earnings Call TranscriptMar 04, 2021$5.8 (-9.99%)Earnings
- Q3 2020 Synthetic Biologics Inc Earnings Call TranscriptNov 10, 2020$3.42 (+3.64%)Earnings
- Q2 2020 Synthetic Biologics Inc Earnings Call TranscriptAug 06, 2020$5.95 (-0.45%)Earnings
- Q1 2020 Synthetic Biologics Inc Earnings Call TranscriptMay 05, 2020$3.48 (+2.21%)Earnings
- Q4 2019 Synthetic Biologics Inc Earnings Call TranscriptFeb 20, 2020$5 (-3.74%)Earnings
- Q3 2019 Synthetic Biologics Inc Earnings Call TranscriptNov 04, 2019$4.5 (+6.28%)Earnings
- Q2 2019 Synthetic Biologics Inc Earnings Call TranscriptAug 08, 2019$4.7 (+0.09%)Earnings
- Q1 2019 Synthetic Biologics Inc Earnings Call TranscriptMay 08, 2019$6.02 (-2.89%)Earnings
- Q4 2018 Synthetic Biologics Inc Earnings Call TranscriptFeb 27, 2019$6.5 (-2.40%)Earnings
Q3 2022 Theriva Biologics Inc Earnings Call Transcript
Good day, and welcome to Theriva Biologics, formerly Synthetic Biologics, 2022 third quarter operational highlights and financial results. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Chris Calabrese, LifeSci Advisors Relationship Manager. Please go ahead, sir.
Thank you, operator, and good morning, everyone. Welcome to the Theriva Biologics 2022 Third Quarter Investor Conference Call. Leading the call today will be Steven Shallcross, Chief Executive and Chief Financial Officer of Theriva Biologics. Dr. Manel Cascalló, General Director of Theriva Biologics European subsidiary; Dr. Frank Tufaro, Chief Operating Officer; and Dr. Vince Wacher, Head of Corporate and Product Development of Theriva Biologics, are also on the call and will be available to answer questions during the Q&A session.
Theriva Biologics issued a press release last evening, which provided operational highlights and included the financial results for the third quarter ending September 30, 2022. The press release can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)